KPRX - KIORA PHARMACEUTICALS INC
1.98
-0.050 -2.525%
Share volume: 45,313
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$2.03
-0.05
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-10-2024 | 08-09-2024 | 11-08-2024 | 03-25-2025 | 05-09-2025 | 08-08-2025 | 11-07-2025 | |
| Total revenue | 16.000 M | 20.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 16.000 M | 20.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -99.88% | -100.00% | nan% | nan% | nan% | ||||
| Operating expenses | 2.790 M | 2.445 M | 2.698 M | 5.452 M | 4.021 M | 3.944 M | 4.174 M | |
| Selling general and admin | 1.296 M | 1.538 M | 1.381 M | 1.327 M | 1.489 M | 1.354 M | 1.444 M | |
| Research and development | 1.494 M | 906.680 K | 1.317 M | 4.125 M | 2.532 M | 2.590 M | 2.730 M | |
| Total expenses | 2.778 M | 2.565 M | 3.602 M | 2.565 M | 2.330 M | 2.396 M | 794.437 K | |
| -7.67% | 40.44% | -28.80% | -9.14% | 2.83% | -66.85% | |||
| Operating income | 13.222 M | -2.545 M | -3.602 M | -2.565 M | -2.330 M | -2.396 M | -794.437 K | |
| Ebit | 13.230 M | -2.564 M | -3.662 M | -2.576 M | -2.347 M | -2.490 M | -818.145 K | |
| Pretax income | 13.453 M | -2.222 M | -3.413 M | -2.158 M | -2.070 M | -2.265 M | -616.323 K | |
| -116.51% | 53.64% | -36.76% | -4.10% | 9.40% | -72.78% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 123.006 K | -112.057 K | -643.129 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 13.453 M | -2.222 M | -3.413 M | -4.224 M | -2.193 M | -2.152 M | 26.806 K | |
| -116.51% | -53.64% | -23.74% | 48.08% | 1.85% | 101.25% |